The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

Add Yahoo as a preferred source to see more of our stories on Google. People with ADHD have trouble with attention, organisation, time management and self-control Attention deficit hyperactivity ...

Impulsivity, hyperactivity, and difficulty concentrating are some of the symptoms associated with attention deficit ...

Research shows that eating nutritious meals helps the brain function optimally, but numerous social media posts are claiming ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one ...

Understood reports children with ADHD are more likely to struggle with motor skills, highlighting the importance of early ...

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and ...

For years, people thought that attention deficit hyperactivity disorder (ADHD) was a problem that only kids had. It was ...

With an expiration date still more than a year away, here's what the latest details reveal.